跳至主要内容
临床试验/NCT00654394
NCT00654394已完成3 期

Randomized, Double-Blind, Multicenter, Trial to Assess the Effect of High & Low Doses of ZD4522 on Progression of Carotid Artery Atheroma in Moderately Hypercholesterolemic Subjects With Asymptomatic Carotid Stenosis After 24 Months of Dosing.

AstraZeneca0 个研究点目标入组 200 人开始时间: 2000年1月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
已完成
发起方
AstraZeneca
入组人数
200
主要终点
Changes in carotid wall volume as measured by MRI scan

研究概览

简要总结

The purpose of this study is to examine the changes in the carotid artery when subjects receive high or low doses of rosuvastatin.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Fasting blood low density lipoprotein cholesterol level as defined by the protocol
  • Diagnosed carotid arterial stenosis

排除标准

  • The use of lipid lowering drugs or dietary supplements after Visit
  • Heavy or total occlusion of the carotid artery or recent stroke
  • Uncontrolled hypertension, hypothyroidism, alcohol or drug abuse

研究组 & 干预措施

1

Experimental

干预措施: Rosuvastatin (Drug)

结局指标

主要结局

Changes in carotid wall volume as measured by MRI scan

时间窗: At 40 weeks and 104 weeks

次要结局

  • Safety: adverse events & abnormal laboratory markers(2 weekly for first 4 weeks then 4 weekly)
  • Other changes in the structure and composition of the carotid arterial wall as defined in the protocol.(At 40 weeks and 104 weeks)

研究者

发起方
AstraZeneca
申办方类型
Industry

相似试验